OBD Rule Changes Effective January 1, 2019
Oregon Pain Guidance - Oregon Health Authority
The Oregon state resouce for healthcare professionals treating pain. For information on the following subjects and more please visit the Oregon Pain Guidance - Website
- Pain Treatment Guidelines
- Non-Opioid Options
- Treating Pain in Children and Adolescents
- Recommended Opioid Policy for Dentists
DEQ - EPA Dental Rule Compliance
Questions regarding the DEQ - EPA Dental Rule Compliance should be directed to:
Pretreatment Program Coordinator
Cultural Competence Continuing Education (CE)
HB2611 was passed into law (ORS 413.450), creating requirements for Oregon Health Authority (OHA), through Office of Equity and Inclusion (OEI), to provide resources and support for improving the cultural competence of regulated health care professionals in Oregon and to report to the Oregon Legislative Assembly about their level of participation in cultural competence education. (Cultural Competence CE Brief
- The OBD encourages all Licensees to pursue ongoing continuing education opportunities in cultural competency.
- The OBD considers cultural competency relevant to the current practice of all licensees, and licensees may use this CE towards their required CE hours. However, please note that the OBD has no hourly requirement for CE in cultural competency.
Find an OHA-Approved CCE Training
- This is a growing list of OHA-approved training opportunities, based upon criteria for high quality cultural competency education: Registry.
- As the registry is updated on a regular basis, please check back frequently for changes.
Prescription Drug Monitoring Program
Legislation was passed in February 2018, along with rules enacted by the OHA requiring all dentists with an Oregon active Drug Enforcement Administration (DEA) registration to register with the PDMP by July 1, 2018.
If you have any trouble registering, please contact the PDMP directly, their email address is email@example.com
At its Board Meeting on December 14, 2018, the Board of Dentistry recognized that it is within the scope of practice for a licensee to perform in-office A1C diabetes screening test for at-risk patients. The Board noted that: a) such testing is not presumed to be the standard of care; and b) for A1C screenings beyond the normal range, licensees should refer patients to a physician for a formal evaluation, diagnosis, and treatment.
For information regarding HbA1c testing, the American Dental Association has published a guide point of care, diabetes testing and reporting.